Innovative biomarker discovery and validation
WHAT WE DO
Genomic or protein-based biomarker?
It depends on the question you’re asking – ask BioXpedia as a first step!
What scientists are saying about BioXpedia
“Current research deals intensively with analysis of blood and urine to identify novel biomarkers. One of the challenges is to develop sensitive and specific methods to identify disease-associated molecules in complex clinical samples. I am convinced that the new sensitive methods for measuring biomarker signatures will become an important tool in biomarker research.”Lars Dyrskjøt Andersen,
”We are used to measuring 1-2 relations at a time, while this type of panels make it possible to broaden the analysis, so that we at one time fast and precisely may measure the content of several substances and proteins in a biopsy. If this screening method holds its promise, it is fantastic. It might turn out to be of huge importance to guiding us and giving an overview of the identification process to find disease markers”Kristian Stengaard-Pedersen
The Fast Track to precision medicine!
- Time-, cost-, and sample effective
- Rapid and reproducible
- High multiplex level
- Automated workflow
- Maximum reproducibility and efficiency
- Effective QC tools
Proximity Extension Assay – protein biomarkers
High-Throughput qPCR – miRNA, RNA and SNP
Extraction and sample preparation
nanoString – DNA, RNA and protein
BioXpedia A/S is a contract research laboratory founded in 2016 by CEO Mogens Kruhøffer to provide high quality cost effective targeted biomarker screening to pre-clinical and clinical researchers. Our main focus is on the identification of new clinically useful biomarkers for patient stratification, treatment response, and discovery of potential drug targets.